Back to Spiriva Capsule

Spiriva Capsule Uses in Pakistan

Spiriva Capsule (tiotropium bromide 18mcg) is a long-acting bronchodilator prescribed in Pakistan for COPD. This guide covers all its approved uses, indications, and important information you should know.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated:

Uses

Quick Answer

Spiriva Capsule (tiotropium bromide 18mcg) is used for COPD maintenance therapy, chronic bronchitis, and emphysema. It belongs to the LAMA class and is inhaled via HandiHaler — never swallowed. Always take it as directed by your doctor or pharmacist.

Primary Uses at a Glance

COPD Maintenance Therapy

Spiriva Capsule is used for COPD maintenance therapy to reduce breathlessness and improve airflow in patients with chronic obstructive pulmonary disease. This is the primary approved indication for tiotropium in Pakistan.

As prescribed by your doctor. Standard adult dose: one capsule via HandiHaler once daily.

Chronic Bronchitis

Spiriva Capsule is used for chronic bronchitis, a form of COPD characterised by persistent cough and mucus production. Tiotropium relaxes airway muscles and improves airflow. This is a primary approved indication in Pakistan.

As prescribed by your doctor. Standard adult dose: one capsule via HandiHaler once daily.

Emphysema

Spiriva Capsule is used for emphysema, in which air sacs in the lungs are damaged and airflow is permanently reduced. Tiotropium helps open remaining airways and reduce breathlessness. This is a primary approved indication in Pakistan.

As prescribed by your doctor. Standard adult dose: one capsule via HandiHaler once daily.

Other Uses

  • Reducing COPD exacerbations (flare-ups)
  • Improving exercise tolerance in COPD patients

Spiriva Capsule Uses (Fayde / Kis kaam aati hai)

Spiriva Capsule contains tiotropium bromide 18mcg and belongs to the Long-Acting Muscarinic Antagonist (LAMA) group. Below are all the approved and common uses of Spiriva Capsule in Pakistan.

Important: Spiriva Capsule is for inhalation only via the HandiHaler device. It must never be swallowed.

Primary Uses (Mukhya Istemal)

  • COPD (chronic obstructive pulmonary disease) maintenance therapy
  • Chronic bronchitis
  • Emphysema

Who Should Take It (Kin logon ke liye)

  • Adults diagnosed with COPD
  • Patients with persistent breathlessness requiring daily maintenance therapy
  • Patients who have not achieved adequate control with short-acting bronchodilators alone

When NOT to Use Spiriva Capsule (Kab nahi leni chahiye)

  • If you are allergic to tiotropium, ipratropium, or any ingredient
  • For acute bronchospasm or sudden breathing attacks (not a rescue inhaler)
  • If you have narrow-angle glaucoma or severe urinary retention without specialist guidance

Summary

Spiriva Capsule is prescribed for COPD, chronic bronchitis, and emphysema. It is a maintenance medicine — not for acute breathing attacks. Always consult a doctor before starting or stopping this medicine.

The information in this guide is for educational purposes only.

Frequently Asked Questions

For which conditions is Spiriva Capsule most effective?

Spiriva Capsule is most effective for COPD maintenance therapy, chronic bronchitis, and emphysema. Always take it for the condition your doctor has prescribed it for.

Can Spiriva Capsule be taken without a doctor's prescription?

Spiriva Capsule is a prescription medicine. Do not take it without a doctor's advice. It requires correct technique with the HandiHaler device.

How long does Spiriva Capsule take to show results?

Tiotropium begins to open airways within about 30 minutes of inhalation and its effect lasts approximately 24 hours. Improvement in breathlessness may be noticed within days to weeks of regular use.

Can Spiriva Capsule be taken long-term?

Yes, Spiriva Capsule is a maintenance medicine intended for long-term daily use in COPD. Your doctor will monitor lung function and side effects during continued treatment.

What should I do if Spiriva Capsule does not seem to work?

If breathlessness is not improving, do not increase the dose on your own. Consult your doctor to review your COPD management plan.

Sources

  1. DRAP Registered Products Database Drug Regulatory Authority of Pakistan
  2. WHO Model List of Essential Medicines, 23rd ed. (2023) World Health Organization
  3. British National Formulary (BNF) BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.